Literature DB >> 7908061

Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo.

P Bagnarelli1, A Valenza, S Menzo, A Manzin, G Scalise, P E Varaldo, M Clementi.   

Abstract

The dynamics of viral activity during different phases of human immunodeficiency virus type 1 (HIV-1) infection were investigated by competitive PCR methods. In particular, we studied the time course of three quantitative molecular parameters of viral activity (genomic RNA copy number in plasma and provirus and late HIV-1 transcript molecule copy numbers in peripheral blood CD4+ T lymphocytes) in untreated patients and patients treated with specific anti-HIV-1 compounds. The results shown here indicate that direct RNA parameters are quantitative molecular indices sensitive enough to be used for a more accurate evaluation of the natural history of this infection and that an indirect parameter, the mean transcriptional activity for each provirus in CD4+ T lymphocytes, may be important in studying this infection in vivo at the molecular level. A dramatic decrease of the indices was evident at seroconversion, but the quantitative values were virtually stable throughout the time the untreated patients were studied during the clinical latency phase. Furthermore, the results indicate that an early response to antiretroviral compounds is detected in most subjects as a decrease in the viral activity level.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908061      PMCID: PMC236727     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.

Authors:  D P Burns; R C Desrosiers
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  Projections of AIDS morbidity and mortality in San Francisco.

Authors:  G F Lemp; S F Payne; G W Rutherford; N A Hessol; W Winkelstein; J A Wiley; A R Moss; R E Chaisson; R T Chen; D W Feigal
Journal:  JAMA       Date:  1990-03-16       Impact factor: 56.272

3.  Quantitative analysis of human immunodeficiency virus type-1 DNA in asymptomatic carriers using the polymerase chain reaction.

Authors:  S Oka; K Urayama; Y Hirabayashi; K Ohnishi; H Goto; K Mitamura; S Kimura; K Shimada
Journal:  Biochem Biophys Res Commun       Date:  1990-02-28       Impact factor: 3.575

4.  Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.

Authors:  G Gilliland; S Perrin; K Blanchard; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  Plasma viremia in human immunodeficiency virus infection.

Authors:  R W Coombs; A C Collier; J P Allain; B Nikora; M Leuther; G F Gjerset; L Corey
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

6.  Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group.

Authors:  A Muñoz; M C Wang; S Bass; J M Taylor; L A Kingsley; J S Chmiel; B F Polk
Journal:  Am J Epidemiol       Date:  1989-09       Impact factor: 4.897

7.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers.

Authors:  P Simmonds; P Balfe; J F Peutherer; C A Ludlam; J O Bishop; A J Brown
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees.

Authors:  K Saksela; E Muchmore; M Girard; P Fultz; D Baltimore
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

Authors:  S J Clark; M S Saag; W D Decker; S Campbell-Hill; J L Roberson; P J Veldkamp; J C Kappes; B H Hahn; G M Shaw
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

10.  Quantitation of HIV-1 proviral DNA relative to cellular DNA by the polymerase chain reaction.

Authors:  D E Kellogg; J J Sninsky; S Kwok
Journal:  Anal Biochem       Date:  1990-09       Impact factor: 3.365

View more
  15 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.

Authors:  M Comar; C Simonelli; S Zanussi; P Paoli; E Vaccher; U Tirelli; M Giacca
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 3.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  High susceptibility of U937-derived subclones to human immunodeficiency virus type 1 infection correlates with accumulation of unintegrated circular viral DNA.

Authors:  M Kameoka; T Kimura; Y Okada; K Fujinaga; T Nakaya; H Takahashi; M Kishi; K Ikuta
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

5.  Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.

Authors:  P Bagnarelli; A Valenza; S Menzo; R Sampaolesi; P E Varaldo; L Butini; M Montroni; C F Perno; S Aquaro; D Mathez; J Leibowitch; C Balotta; M Clementi
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 6.  Quantitative molecular methods in virology.

Authors:  M Clementi; S Menzo; A Manzin; P Bagnarelli
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort.

Authors:  N L Michael; T Mo; A Merzouki; M O'Shaughnessy; C Oster; D S Burke; R R Redfield; D L Birx; S A Cassol
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

8.  Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.

Authors:  O J Cohen; G Pantaleo; M Holodniy; S Schnittman; M Niu; C Graziosi; G N Pavlakis; J Lalezari; J A Bartlett; R T Steigbigel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

9.  Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs.

Authors:  Milena Furione; Renato Maserati; Marta Gatti; Fausto Baldanti; Agostino Cividini; Raffaele Bruno; Giuseppe Gerna; Mario U Mondelli
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.

Authors:  P Bagnarelli; S Menzo; A Valenza; S Paolucci; S Petroni; G Scalise; R Sampaolesi; A Manzin; P E Varaldo; M Clementi
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.